BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15085916)

  • 1. Construct validity of the RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes.
    Maddigan SL; Feeny DH; Johnson JA;
    Qual Life Res; 2004 Mar; 13(2):435-48. PubMed ID: 15085916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes.
    Maddigan SL; Feeny DH; Johnson JA;
    Med Decis Making; 2003; 23(6):489-501. PubMed ID: 14672109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life deficits associated with varying degrees of disease severity in type 2 diabetes.
    Maddigan SL; Majumdar SR; Toth EL; Feeny DH; Johnson JA;
    Health Qual Life Outcomes; 2003 Dec; 1():78. PubMed ID: 14675484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial.
    Raisch DW; Feeney P; Goff DC; Narayan KM; O'Connor PJ; Zhang P; Hire DG; Sullivan MD
    Cardiovasc Diabetol; 2012 Jul; 11():35. PubMed ID: 22515638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes.
    Johnson JA; Maddigan SL
    Qual Life Res; 2004 Mar; 13(2):449-56. PubMed ID: 15085917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence on the construct validity of the Health Utilities Index Mark 2 and Mark 3 in patients with chronic kidney disease.
    Davison SN; Jhangri GS; Feeny DH
    Qual Life Res; 2008 Aug; 17(6):933-42. PubMed ID: 18543076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness and construct validity of the health utilities index in patients with dementia.
    Kavirajan H; Hays RD; Vassar S; Vickrey BG
    Med Care; 2009 Jun; 47(6):651-61. PubMed ID: 19433998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal construct validity of the Health Utilities Indices Mark 2 and Mark 3 in hip fracture.
    Jones CA; Pohar SL; Feeny DH; Eng K
    Qual Life Res; 2014 Apr; 23(3):805-13. PubMed ID: 24081869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease.
    Neumann PJ; Sandberg EA; Araki SS; Kuntz KM; Feeny D; Weinstein MC
    Med Decis Making; 2000; 20(4):413-22. PubMed ID: 11059474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Utilities Index mark 3 demonstrated construct validity in a population-based sample with type 2 diabetes.
    Maddigan SL; Feeny DH; Majumdar SR; Farris KB; Johnson JA
    J Clin Epidemiol; 2006 May; 59(5):472-7. PubMed ID: 16632135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United States.
    Luo N; Johnson JA; Shaw JW; Coons SJ
    Med Care; 2009 Jan; 47(1):53-60. PubMed ID: 19106731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutual concurrent validity of the child health questionnaire and the health utilities index: an exploratory analysis using survivors of childhood cancer.
    Nixon Speechley K; Maunsell E; Desmeules M; Schanzer D; Landgraf JM; Feeny DH; Barrera ME
    Int J Cancer Suppl; 1999; 12():95-105. PubMed ID: 10679879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construct validity for the Health Utilities Index in a sleep center.
    Welch KC; Scharf SM
    Sleep Breath; 2007 Dec; 11(4):295-303. PubMed ID: 17457630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cohort study found the RAND-12 and Health Utilities Index Mark 3 demonstrated construct validity in high-risk primary care patients.
    Feeny D; Farris K; Côté I; Johnson JA; Tsuyuki RT; Eng K
    J Clin Epidemiol; 2005 Feb; 58(2):138-41. PubMed ID: 15680746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misinterpretation with norm-based scoring of health status in adults with type 1 diabetes.
    Supina AL; Feeny DH; Carroll LJ; Johnson JA
    Health Qual Life Outcomes; 2006 Mar; 4():15. PubMed ID: 16542446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: group- and individual-level comparisons.
    Feeny D; Furlong W; Saigal S; Sun J
    Soc Sci Med; 2004 Feb; 58(4):799-809. PubMed ID: 14672594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon's indices.
    Bas Janssen MF; Birnie E; Bonsel GJ
    Qual Life Res; 2007 Jun; 16(5):895-904. PubMed ID: 17294285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer.
    Bowker SL; Pohar SL; Johnson JA
    Health Qual Life Outcomes; 2006 Mar; 4():17. PubMed ID: 16553957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the psychometric properties of generic utility measures in multiple sclerosis.
    Kuspinar A; Mayo NE
    Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A parent-child dyad approach to the assessment of health status and health-related quality of life in children with asthma.
    Ungar WJ; Boydell K; Dell S; Feldman BM; Marshall D; Willan A; Wright JG
    Pharmacoeconomics; 2012 Aug; 30(8):697-712. PubMed ID: 22788260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.